Wegovy medicine price in the UK: what the number really includes

Free clinical consultation, assessed the same day by a GPhC-registered Independent Prescriber
Prescription fee and medicine included at one transparent price — no extras added at checkout
Free next-working-day tracked delivery by DPD, in plain unbranded packaging
Priority aftercare seven days a week, with every repeat order clinically re-reviewed before dispatch

In the UK, Wegovy is a prescription-only medicine for weight management, and private pricing typically runs from around £149 to £375 per month depending on the dose and the provider you use. Those figures have shifted since Eli Lilly raised Mounjaro's list price in September 2025, pulling the wider GLP-1 market upward with it. What the headline number rarely tells you is what's bundled in — and for a prescription medicine like semaglutide, that gap between the quoted price and the total cost of a properly run service matters quite a lot. Wegovy (semaglutide) is a prescription-only medicine; a prescriber must assess your suitability before it can be dispensed.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

Why Wegovy pricing varies so much, and what to check before you pay

The misconception most people arrive with

A lot of people searching for the price of Wegovy assume it works like buying a supplement online: find the lowest listing, add to basket, done. It's an understandable assumption, and it's the one worth setting aside first, gently, because Wegovy is a Prescription-Only Medicine (POM). Under UK law, it can only be legally supplied following a clinical assessment and a valid prescription. So the price you're comparing is never just a product price; it's always the cost of a service built around a prescription.

That distinction changes how you read a price table. A figure that looks cheap may reflect a provider that has stripped the clinical layer down to a checkbox questionnaire rather than a genuine prescriber review. It may exclude your initial consultation fee, the prescription charge, or delivery. Some providers bill monthly by subscription, cancelling mid-cycle can create its own complications. The NICE appraisal of semaglutide for weight management sets out clinical criteria for appropriate use; those criteria exist for a reason, and a rushed assessment serves no one.

None of this means private Wegovy treatment is unaffordable, it means the number you see first isn't the whole picture.

How UK private Wegovy pricing is structured in practice

Private providers typically price per pen, aligned to the four-weekly injection schedule, so costs change as the dose is titrated upward. The starting dose is 0.25 mg, climbing through 0.5 mg, 1.0 mg and 1.7 mg toward the 2.4 mg maintenance level, with each step determined by the prescriber. If you want to understand what you're likely to pay at a specific point in that titration, our page on what the 1 mg dose costs covers that step in detail. A newly approved 7.2 mg dose is also now MHRA-licensed, you can read about the background to that on the Wegovy price overview page. Because patients spend different amounts of time at different doses, monthly spend varies over the course of treatment.

Against that backdrop, market pricing since late 2025 has broadly settled somewhere between £149 and £375 per month across doses and providers, figures that are widely reported and carry the usual caveats about market movement. Some providers quote that lower end but do not include the consultation or prescription; if you want to see how those totals stack up across routes, our page on buying Wegovy online and what it actually costs sets out a clear comparison. NHS England's guidance on weight management injections gives a clear account of what a properly supported treatment course should look like, useful reading when you're trying to work out what any provider's quoted price should cover.

What a single transparent price should include

At nume, a named prescriber (a real clinician, not software) reads your consultation the same day. If approved, your treatment is dispatched before the end of that working day for free next-working-day delivery by DPD. One price covers the consultation, prescription, medicine and delivery. There are no subscriptions and no automatic renewals; every repeat order is reviewed clinically before anything is sent. You can read more about the team behind those reviews on the clinical team page.

We are not the cheapest option on the market, and that's a deliberate choice. A lower price built on a stripped-back clinical service isn't a saving in any meaningful sense. Priority aftercare seven days a week costs something to run. So does photo-ID verification, live weight checks, and GP notification in line with GPhC guidance. Those aren't optional extras; they're what makes the treatment safe. For a fuller look at how total costs compare across private routes, the Wegovy cost and price breakdown page walks through what to look for line by line.

Price is the wrong test for a prescription medicine

The MHRA has warned publicly about counterfeit weight-loss pens sold online, in some cases fake pens have been found to contain insulin, with serious consequences for people who received them. Large quantities of illegally traded GLP-1 medicines have been seized across the UK. The red flags are consistent: sellers offering these medicines without a prescription, prices noticeably below the market range, promotional codes from accounts you've never heard of. You can verify any online pharmacy against the GPhC register at pharmacyregulation.org; a legitimate pharmacy is on it. Suspect sellers can be reported via the MHRA Yellow Card scheme.

For a medicine that requires a prescriber to assess your weight, your medical history and your other medications before it is dispensed, the cheapest listing answers the wrong question. The question worth asking is whether the price you're paying covers genuine clinical oversight, a verified supply chain, and support if anything changes after you start. If you'd like to find out whether Wegovy is clinically suitable for you, a free consultation is the right place to begin, and our prescribers review every treatment request on its individual merits.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions